Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 December, 2018 19:21 IST
Fitch affirms Indian Oil Corporation at 'BBB-'; outlook stable
Source: IRIS | 17 Jul, 2018, 10.31AM
Comments  |  Post Comment

Fitch Ratings has affirmed Indian Oil Corporation (IOC) Long-Term Foreign-Currency Issuer Default Rating (IDR) at 'BBB-'. The outlook is stable. The agency has also affirmed IOC's (Q,N,C,F)* senior unsecured rating and the ratings on its outstanding senior unsecured debt at 'BBB-'.

Fitch equalises the India-based company's rating with that of its largest shareholder, the state of India (BBB-/Stable), based on Fitch's Government-Related Entities (GRE) Rating Criteria.

We have assessed IOC's standalone profile at 'BB+' to reflect its dominant market position as the largest oil refining and marketing company (OMC) in India, the average-but-improving complexity of its refining assets and a moderate financial profile. High capex requirements are likely to keep free cash flows negative over the next few years.

Shares of the company gained Rs 4.4, or 2.8%, to trade at Rs 161.75. The total volume of shares traded was 318,228 at the BSE (10.18 a.m., Tuesday).

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Commercial Engg & Body Builders Co bags order worth Rs 1.52 bn - 19-Dec-2018 10:51
Glenmark Pharma forays into dermatology segment in U.S - 19-Dec-2018 10:33
M&M to hike stake in associate company Sampo Rosenlew - 18-Dec-2018 10:37
Glenmark Pharma gets nod for Fluocinolone Acetonide oil - 18-Dec-2018 10:08
BGR Energy Systems bags order worth Rs 494 mn from Tamilnadu Transmission Corp - 18-Dec-2018 10:04
Lupin receives approval from USFDA for Clobazam tablets - 18-Dec-2018 10:01
Ahluwalia Contracts (India) secures new order worth RS 4.25 bn - 17-Dec-2018 15:31
Lupin receives tentative USFDA approval for Tadalafil tablets - 17-Dec-2018 14:49
Gayatri Projects bags new order worth Rs 4.93 bn - 17-Dec-2018 09:43
Zydus Cadila receives USFDA approvals for two drugs - 17-Dec-2018 09:39
Biocon's API manufacturing facility completes USFDA inspection - 17-Dec-2018 09:36
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer